11th Dec 2015 06:44
LONDON (Alliance News) - AstraZeneca PLC has teamed up with the Swedish government and the Wallenberg family to invest USD100.0 million in a new research centre, the Financial Times reported.
The pair will work together on developing new technologies for discovering and manufacturing new drugs, the FT said, following on from AstraZeneca's announcement in May that it would build a new USD285.0 million production facility in Sweden.
https://next.ft.com/content/780af5c8-9f38-11e5-8613-08e211ea5317
The group has also won a partial victory in its battle with The National Institute for Health and Clinical Excellence, the NHS drug cost watchdog, over access to a new medicine for ovarian cancer, the FT said.
NICE said on Friday it would be willing to recommend olaparib, also known as Lynparza, for use by the NHS England, reversing its June decision to reject the drug.
This was only secured, however, after AstraZeneca agreed to cut the price of the drug and fund some treatment costs in concession.
https://next.ft.com/content/6b8d9cca-9f4b-11e5-8613-08e211ea5317
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Astrazeneca